PSNC monitoring generics shortages as Bristol Labs suspension extended

PSNC has told C+D it will continue to monitor generics shortages “very closely” after Bristol Laboratories had its manufacturing suspension extended.

exclusive
empty%20medicine_620.jpg
MHRA has stressed there is no evidence of defective medicines

Latest from News

More from Business